KIMBERLY COX: Open Payments
NPI 1205805074 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 66 payments from 20 companies in 2025. Trend: 2023 $916 · 2024 $1,309 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $261 |
| Novo Nordisk Inc | 11 | $168 |
| PFIZER INC. | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Lilly USA, LLC | 6 | $90 |
| Corcept Therapeutics | 4 | $60 |
| Dexcom, Inc. | 3 | $54 |
| Edwards Lifesciences Corporation | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
Products named: UBRELVY, NURTEC ODT, Kerendia, VRAYLAR, MOUNJARO, Ozempic, Korlym, Rybelsus.
Industry payments across SC — which companies pay providers there.
